Decon SA
2.0 FTEThe score of Decon shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -2 % Total assets +30 % Headcount (avg FTE) -38 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Decon's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 22 Aug 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Decon's financial analysis
- Solvency62.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Decon
Decon's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0430.414.536
- VAT number
- BE0430414536
- Peppol
- Registered · 0208:0430414536 · as of 09 Nov 2026
- Legal form
- SA
- Incorporated
- 03 Feb 1987
- Registered office
- 3630 Maasmechelen
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Decon (SA) has been based in Maasmechelen since 1987, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 196,616 € and equity of €1.56m; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 62.8%, above the median of its sector (44.2%).
Companies similar to Decon
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Peeters - Petit Retail sale of pharmaceutical products Maasmechelen · balance sheet €5.05m
- Pharmadefi Retail sale of pharmaceutical products Arlon · balance sheet €2.48m
- Gobert Sophie Retail sale of pharmaceutical products Bruges · balance sheet €2.48m
- Tamiphar Retail sale of pharmaceutical products Lasne · balance sheet €2.46m
- Abfab Retail sale of pharmaceutical products Anderlecht · balance sheet €2.46m
- De Witte - De Sutter Retail sale of pharmaceutical products Dendermonde · balance sheet €2.45m
- DE BIE T. Retail sale of pharmaceutical products Affligem · balance sheet €2.45m
- Holsbeek Brecht - Sint -Lenaerts Retail sale of pharmaceutical products Brecht · balance sheet €2.44m
Frequently asked questions about Decon
What is the revenue of Decon?
Decon files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Decon?
In Belgium, the VAT number is the company number prefixed with BE: BE0430414536 for Decon, if the company is VAT-registered. Its company number (CBE) is 0430.414.536.
Where is the registered office of Decon?
According to the CBE register, the registered office of Decon is in 3630 Maasmechelen.
What is the equity of Decon?
At the close of the 2025 financial year, the equity of Decon amounts to 1,560,328 €, a solvency of 62.8% of total assets.
How many people work at Decon?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Decon?
The register lists 5 active mandates at Decon. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Decon
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →